Knowledge Hub

Valuations of behavioral health businesses are shaped by a combination of strong secular demand and payer-driven economics. Demand for mental health , substance use disorder (SUD) , intellectual disabilities and disorders (IDD) , and autism services have increased materially over the past decade, supported by greater awareness, parity legislation, and demographic trends. These tailwinds have historically supported above-average valuation multiples relative to other healthcar

Valuing mental healthcare providers requires a thorough understanding of the diverse care settings and service models within this growing sector. Providers may include outpatient clinics   delivering therapy and medication management, inpatient and residential programs for acute or long-term care, partial hospitalization and intensive outpatient programs (PHP/IOP), telehealth services offering remote therapy, and community-based or school-linked programs. Each type differs in

Valuing autism service providers requires a clear understanding of the broad range of service models that exist within this dynamic sector and how they generate sustainable cash flows. Providers may operate center‑based clinics that deliver structured Applied Behavior Analysis (ABA) and related therapies, in‑home and community‑based services that support individuals in natural environments, school‑based programs integrated with educational services offering long‑term support

Valuing intellectual and developmental disability (IDD) service providers requires a nuanced understanding of the diverse care settings and reimbursement environments that define this segment of the healthcare and social services sector. IDD services encompass a wide array of models, including residential and group homes that offer 24‑hour support, adult day programs focused on habilitation and community engagement, adult foster care and shared‑living arrangements, as well as

The addiction treatment industry is a vital and rapidly evolving segment of the behavioral healthcare market, focused on the diagnosis and treatment of substance use disorders (SUDs), including alcohol, opioids, stimulants, and other drugs. Services range from detoxification and inpatient rehabilitation to outpatient therapy and medication-assisted treatment (MAT). M&A activity in the sector is driven by private equity interest in scalable treatment platforms, especially thos